The New Science of the Eye–Skin Interface

The New Science of the Eye–Skin Interface

Official Position Paper of the World Organization of Dermophthalmology (WOD)

With Classical Greek Foundations & Scientific References

Conceived in Greece

 ABSTRACT

Dermophthalmology is a new, emerging field within Ophthalmology that studies the deep, bidirectional relationship between the eyelid skin, eyelashes, Meibomian and associated glands, the periocular/ocular microbiome, and the ocular surface. All these structures are no longer seen as fragmented parts of different organs, but as components of a single, continuous interface organ: the Ophthalmoderma. This new framework:
  • does not claim a new medical specialty,
  • does not replace Ophthalmology, Dermatology, or Pharmacology,
  • but creates a shared clinical space and scientific language where ophthalmologists, dermatologists, and other health professionals can more comprehensively address diseases of the skin–eye interface.

The need for Dermophthalmology arises from:

  1. The high frequency of ocular involvement in skin diseases such as rosacea, seborrheic dermatitis, atopic dermatitis, and psoriasis, where more than 50–60% of patients present ocular symptoms according to modern studies.
  2. The fact that approximately 86% of dry eye cases are related to Meibomian Gland Dysfunction (MGD) – that is, dysfunction of glands of cutaneous origin.
  3. The observation that, for decades, eye care focused almost exclusively on the cornea, lens, and retina, leaving the eyelids, eyelashes, and lid margin microbiome in a secondary role.
  4. The new living conditions of the 21st century: prolonged screen exposure, urban pollution, air conditioning, face masks, intensive and daily use of periocular cosmetics, contact lens use and population aging – all combine to dramatically increase symptoms of dry eye, blepharitis, irritation, and aesthetic fatigue of the gaze.

Dermophthalmology brings back a crucial but neglected truth:

Vision begins with the skin.The eyelid skin, eyelashes, and cutaneous glands regulate hydration, evaporation, microbiome balance, and the stability of the ocular surface.

This Position Paper:

  • clearly defines the term Dermophthalmology,
  • describes Ophthalmoderma as a new target organ,
  • highlights the importance of eyelids and eyelashes as regulators of hydration and homeostasis,
  • presents the spectrum of dermophthalmologic conditions – from blepharitis and MGD to trichiasis, dark circles, and swollen or droopy eyelids,
  • and proposes a new preventive framework: the “Eye Hygiene Revolution”, analogous to oral hygiene in Dentistry.

KEY DEFINITIONS (Dermophthalmology Glossary)

Dermophthalmology

The field of Ophthalmology that studies the structure, function, and diseases of the skin–eyelid–eyelash–gland–ocular surface interface, in relation to the microbiome and the environment.

Ophthalmoderma

The unified interface organ that includes the eyelid skin, eyelashes and their follicles, Meibomian and associated glands, the lid margin/ocular microbiome, the lipid layer of the tear film, and the ocular surface.

Eye Hygiene

The systematic, daily care of the eyelids, eyelashes, and the tear–skin interface (cleansing, Meibomian gland expression& evacuation, microbiome regulation) as a core pillar of prevention and therapy.

Ophthalmo-Cosmetics

Care products and protocols for eyelids, eyelashes, and periocular skin that are both dermatologically and ophthalmologically safe, respect the Ophthalmoderma, and support both ocular health and the aesthetics of the gaze.

CHAPTER 1 — ANCIENT ROOTS & EPISTEMOLOGICAL BACKGROUND

1.1 Hippocrates — Health as Harmony of Interfaces

In ancient Greek medicine, health was not understood as a property of isolated organs but as harmony of surfaces and balance between the internal and external environment.

In the Hippocratic texts (Peri Opsios / On Vision) we find early ideas that:

  • the eyelid functions as the guardian of the eye,
  • the skin is a boundary with shared nature,
  • and ocular health is tightly linked to the condition of the skin around the eye.

 

Without the modern language of embryology and microbiome, the underlying philosophy is clear: The eye never exists “naked”; it is always clothed by skin, eyelids, and eyelashes.

 1.2 Galen — Glands, Lubrication & Protection

Galen provides detailed descriptions of:

  • the structures of the eyelid,
  • glands and their secretions,
  • the lipid protection of the eye,
  • the function of blinking.

Although terms such as “Meibomian Gland Dysfunction” or “Tear film instability” did not exist, the descriptions clearly refer to a single functional system: skin–glands–tear film–surface.

1.3 The Alexandrian Anatomical School — The First “Tear Film Theory”

The Alexandrian School (3rd century BC) was pivotal in anatomical understanding:

  • Eyelid glands and the marginal zone of the eyelid were described for the first time.
  • A “thin layer of fluid” over the cornea was mentioned – an early shadow of the concept of the tear film.

Dermophthalmology, with modern scientific language, continues this ancient tradition:it returns to the interface, not the isolated organ.

1.4 From Organ to Interface — The Epistemological Leap

For centuries, Medicine organized knowledge around organs:brain, heart, lungs, eye, skin.The interface – the point of contact between two systems – was seen as a mere “boundary,” not a primary target organ.

Dermophthalmology is part of a broader scientific shift:

  • from organ-centric pathology (Virchow),
  • to systemic and microbial ecology,
  • and now to Interface Medicine, where the contact zone takes center stage in prevention and therapy.

CHAPTER 2 — DEFINITION & SCOPE OF DERMOPHTHALMOLOGY

2.1 Formal Definition

Dermophthalmology is:The field of Ophthalmology that studies the structure, function, and diseases of the skin–eyelid–eyelash–gland–ocular surface interface, and their interactions with the microbiome and the environment.

It includes:

  • eyelid skin,
  • eyelash follicle and hair shaft,
  • eyebrow
  • Meibomian, Zeis & Moll glands,
  • lid margin and ocular microbiome,
  • the tear–skin interface,
  • the ocular surface (conjunctiva, cornea, tear film), periocular skin and eyebrows.

2.2 Position Within Medicine

Dermophthalmology:

  • belongs to Ophthalmology,
  • collaborates closely with Dermatology,
  • bridges the gap between skin diseases and ocular involvement,
  • provides a shared language and framework for ophthalmologists, dermatologists, aesthetic physicians, trichologists, and others.

It does not claim a new independent specialty, but proposes a new interdisciplinary field of collaboration.

2.3 Three Foundational Concepts

  1. Ophthalmoderma – the new target organ.
  2. Dual Interface Axes – Meibomian–Follicle Axis (MFA), Tear–Skin Axis (TSA), Ophthalmo–Dermal Interface (ODI).
  3. The Eye Hygiene Revolution – a new preventive paradigm, analogous to oral hygiene.

CHAPTER 3 — OPHTHALMODERMA AS A NEW TARGET ORGAN

Ophthalmoderma is defined as: The unified interface organ that includes the eyelid skin, eyelashes and their follicles, Meibomian and associated glands, the lid margin microbiome, the lipid layer of the tear film, and the ocular surface.

3.1 Dual Interface Functionality

Inward Flow — Skin → Tear Film → Vision
    • Lipid secretion from Meibomian glands
    • Tear film stabilization
    • Reduced evaporation
    • Corneal protection
    • Optical clarity
 

Outward Flow — Tear Film → Blink → Skin/Follicle

  • Regulation of surface moisture
  • Transport of microbial loads
  • Sensory feedback (blink reflex, foreign body sensation)
  • Effects on skin and follicle

Every blink is simultaneously:

  • an act of ocular protection, and
  • an act of skin/follicle regulation.

3.2 The Three Axes of Dermophthalmology

Meibomian–Follicle Axis (MFA)

Links Meibomian glands, hair follicle, and tear film, with bidirectional regulation of lipids, microbiome, and inflammation.

Tear–SkinAxis (TSA)

Thermo-hygrometric and microbial interactions between skin, eyelashes, and tear film.

Ophthalmo–DermalInterface (ODI)

The eyelid margin zone where skin, mucosa, follicles, glands, and tear film meet.

This Position Paper on Dermophthalmology “stands on” the dedicated WOD Position Paper “Ophthalmoderma – The New Target Organ in Dermophthalmology” and serves as a wider framework for the science and philosophy of the new field.

CHAPTER 4 — EMBRYOLOGY & MICROBIOME OF THE OPHTHALMODERMA

4.1 Embryologic Unity — Common Ectodermal Origin

All structures:

  • eyelid skin,
  • eyelash follicle,
  • Meibomian, Zeis, Moll glands,
  • ocular surface,

derive embryologically from the ectoderm.

This implies that they are:

  • histologically related,
  • functionally continuous,
  • pathophysiologically interdependent.

Hence:

  • rosacea, seborrheic dermatitis, psoriasis, atopic dermatitis and others frequently manifest with eyelid/ocular involvement,
  • conversely, chronic ocular surface inflammation often leaves traces on the skin and follicle (erythema, scaling, lash loss).

4.2 The Microbiome as a Shared Ecosystem

The lid margin and ocular microbiome form a continuous ecosystem:

  • Staphylococcus, Corynebacterium, Cutibacterium
  • Demodex folliculorum& brevis
  • and other commensal or potentially pathogenic organisms.

 

Dermophthalmology views:

  • blepharitis not as a “local infection” requiring only antibiotics,
  • but as interface dysbiosis — loss of ecological balance.

The aim is not sterilization, but restoration of a balanced biofilm through:

  • gentle cleansers,
  • thermal regulation,
  • targeted actives (e.g., tea tree oil in appropriate concentrations).

CHAPTER 5 — ANATOMY & FUNCTION: EYELIDS, EYELASHES, GLANDS, OCULAR SURFACE

 

5.1 Eyelid Skin

  • The thinnest skin in the body.
  • Contains sebaceous and sweat glands.
  • Exposed daily to make-up, contact lenses handling, pollutants, allergens, UV, blue light, etc.
  • Regulates local temperature, humidity, pH, and microbiome.

Disorders (erythema, eczema, rosacea, seborrheic changes, psoriatic plaques) lead to changes in sebum and meibum composition, resulting in MGD, blepharitis, tear film instability, edema, and aesthetic fatigue (e.g. dark circles, “tired eyes”).

The follicle:

  • hosts Demodex, bacteria, Zeis/Moll glands,
  • is a micro-ecosystem where hair, lipids, microbes, and immunity meet,
  • connects to nerve endings that trigger the blink reflex.

5.3 Meibomian Glands — The Lipid Factory

  • Modified cutaneous sebaceous glands.
  • Secrete meibum, forming the lipid layer of the tear film.
  • Reduce evaporation, stabilize the optical surface, support comfort.

Meibomian Gland Dysfunction (MGD):

  • induces tear film instability,
  • leads to evaporative dry eye,
  • amplifies inflammation and dry eye symptoms (burning, foreign body sensation, blur).

5.4 Ocular Surface & Tear Film

  • The point where light meets biology.
  • Composed of corneal/conjunctival epithelium and aqueous, mucin, and lipid layers.
  • Constantly remodeled by blinks, gland secretions, and tears.

Tear film stability depends directly on:

  • healthy Meibomian gland function,
  • the state of the eyelid skin,
  • lash length and quality,
  • microbiome composition and balance.

CHAPTER 5A —

THE PHILOSOPHY OF DERMOPHTHALMOLOGY: EYELIDS & EYELASHES AS REGULATORS OF HYDRATION & HOMEOSTASIS

At the core of Dermophthalmology lies the recognition that eyelids and eyelashes are not merely “auxiliary structures” but active regulators of hydration, homeostasis, and protection of the eye.

  1. Eyelids as a “Homeostasis Pump”

Every blink:

  • renews the tear film,
  • distributes Meibomian lipids,
  • regulates evaporation of the aqueous layer,
  • removes debris, make-up, and particles,
  • transfers heat from the skin to the ocular surface.

In other words, every blink is an act of hydration.

  1. Eyelashes as a “Natural Air Conditioner”

Findings from Hu & Mitchell (2015) demonstrated that:

  • ideal lash length (≈ one-third of vertical eye height)
  • creates an air layer,
  • slows airflow,
  • reduces evaporation by up to 50%.

Thus, the eyelash is not a cosmetic ornament; it is a thermo-hygrometric regulator.

  1. The Eyelash Follicle as a Biological Sensor

The follicle:

  • hosts Demodex (biofilm regulator),
  • receives feedback from the microbiome,
  • modulates pH, sebum, local immunity,
  • relays neural signals for the blink reflex.

In other words, the follicle is a sensor initiating ocular surface protection.

 

  1. The Lipid Layer as a “Skin Product”

Meibum (lipids):

  • does not arise from the globe itself,
  • is produced by modified cutaneous sebaceous glands (Meibomian glands).

Therefore:

  • ocular surface hydration depends on cutaneous lipid secretions,
  • the tear film exists thanks to a skin-derived product.

There is no tear film without skin function.

  1. Neglect of the Eyelids → Chronic Ocular Disease

For decades:

  • there was no culture of daily eyelid hygiene,
  • no systematic education on Meibomian gland clearance,
  • therapeutic interventions focused mainly on the ocular surface,
  • many diseases were classified as “chronic and non-curable.”

Dermophthalmology does not blame the medical community. It explains why this occurred:The concept, language, and scientific framework of the interface were missing.

  1. The New Framework

Eye health starts at the skin, not at the cornea.

Eyelids and eyelashes:

  • are the thermo-hygrometric regulators of the eye,
  • the hydration barrier,
  • the aerodynamic stabilizers,
  • the base of the microbiome,
  • the drivers of the lipid layer.

Dermophthalmology, for the first time, treats them:

  • as an organ (Ophthalmoderma),
  • as a homeostatic system,
  • as primary actors in hydration and vision.

CHAPTER 6 — WHY DERMOPHTHALMOLOGY IS NEEDED TODAY

6.1 Limitations of the Old Model

The classical model:

  • focused on cornea, lens, and retina,
  • addressed ocular surface disorders mainly with drops, gels, antibiotics, and anti-inflammatories,
  • did not incorporate the concept of routine managed eyelid and eyelash hygiene.

In eyes with:

  • dirty, inflamed lids,
  • obstructed Meibomian glands,
  • microbiome dysbiosis,
  • long-standing neglect,

no pharmacological treatment can reach its full potential.This is not a “mistake” of Ophthalmology; it is an evolutionary step of the model.

6.2 The explosion of ocular symptoms in skin diseases

Studies show that:
  • in rosacea, up to 58% of patients have ocular involvement,
  • in seborrheic dermatitis, about 40–45% have eyelid/ocular symptoms,
  • in atopic dermatitis, 60–90% present with dry eye, redness, eyelid itching,
  • in psoriasis, a significant proportion shows eyelid and ocular involvement.
In practice: a large portion of “ocular” patients are actually dermo-ocular patients.Without a common language between Ophthalmology and Dermatology, many patients feel they shuttle between specialties without an integrated plan. Dermophthalmology proposes:
  • a shared framework,
  • shared concepts,
  • co-management where needed,
and a clear map of dermo-ocular involvement.

6.3 WHY NOW?

New lifestyle conditions, the digital era, and rising disease prevalence make Dermophthalmology especially urgent.

6.3.1 The Screen Era

Over the last 20–30 years:

  • the average adult spends many hours per day in front of screens (computers, smartphones, tablets),
  • blink rate is reduced by up to 50%,
  • tear film evaporation increases,
  • visual fatigue and dry eye skyrocket.

Compared to 1980–1990, reports of dry eye symptoms and “tired eyes” have multiplied, especially among young adults and teenagers.

Dermophthalmology responds by:

  • explaining how reduced blinking disrupts Meibomian function and tear film,
  • proposing daily hygiene and eyelid ergonomics protocols for the digital age.

6.3.2 Urban Pollution, Air Conditioning & Climate Change

Additional factors:

  • particulate air pollution,
  • air conditioning in closed spaces,
  • low humidity,
  • climate shifts,
  • smoke, dust, allergens.

In recent years:

  • reports of irritation, red eyes, and stinging have increased,
  • seasonal allergies have expanded,
  • many patients report symptom worsening in urban environments.

Dermophthalmology:

  • views the eyelid skin as a first line of defense against pollution,
  • focuses on removal of pollutants and allergens at the skin–eye interface.

6.3.3 Beautification of the Gaze & Makeup-Induced Blepharitis

Contemporary beauty culture involves:

  • intense, daily eye make-up,
  • pencils, eyeliners, shadows, 24h mascaras, lash extensions, lash lifting,
  • aggressive periocular aesthetic procedures.

Within two–three decades:

  • products once reserved for “evening looks” became daily routine,
  • accumulation of cosmetics, biofilm, and micro-debris on lids and lashes increased exponentially,
  • Makeup-Induced Blepharitis (MIB) emerged as a recognizable clinical entity.

 

 

 

 

 

 

Dermophthalmology:

  • acknowledges this new reality,
  • does not demonize beauty,
  • but introduces the concept of “dermo-ocular safe” products and the need for daily removal of cosmetics with respect for the Ophthalmoderma.

6.3.4 Aging, Dark Circles, Swollen & “Droopy” Lids

The global population is aging:

  • eyelid laxity, dermatochalasis, lid edema,
  • dark circles (vascular, structural, or microcirculatory),
  • “bags,” morning puffiness.

These are not purely cosmetic concerns:

  • they affect visual comfort,
  • relate to inflammation, microcirculation, lymphatic drainage,
  • often accompany MGD, blepharitis, tear film instability.

Dermophthalmology:

  • does not claim to replace surgical or aesthetic procedures (e.g. blepharoplasty, fillers, lasers),
  • but offers a new perspective: aesthetic manifestations of the gaze are often part of a continuous spectrum with functional health of the Ophthalmoderma.

6.3.5 From Silent Epidemics to a New Paradigm

In a matter of decades:

  • cases of dry eye and blepharitis have increased significantly,
  • they appear at younger ages,
  • they are tied to new behaviors (screens, make-up, contact lenses, air-conditioning).

Dermophthalmology is Medicine’s answer to this new, multifactorial reality.

CHAPTER 7 — DISEASES OF DERMOPHTHALMOLOGY

 

Dermophthalmology is not limited to “classic” ocular surface disorders. It encompasses a wide spectrum of conditions with a common denominator: disturbance of the skin–eyelid–lash–gland–tear film–ocular surface interface.

 

7.1 Primary Dermophthalmologic Disorders

  • Blepharitis (seborrheic, staphylococcal, mixed, Demodex-associated)
  • Meibomian Gland Dysfunction (MGD)
  • Chalazion / chronic obstructive Meibomian cysts
  • Ocular rosacea (dermo-ocular rosacea)
  • Periocular dermatitis (including eyelid eczema)
  • Demodicosis of the eyelids
  • Folliculitis / madarosis (eyelash loss)
  • Trichiasis / Distichiasis (misdirected or additional lashes irritating the surface)
  • Tear film instability & evaporative dry eye
  • Makeup-Induced Blepharitis (MIB) – inflammation and dysfunction from chronic cosmetic use

 

 

7.2 Secondary & Associated Conditions

  • Entropion / Ectropion with cutaneous–muscular component
  • Atopic keratoconjunctivitis with strong dermo-ocular involvement
  • Allergic/irritant contact dermatitis from cosmetics, cleansers, contact lenses and solutions
  • Eyelid infections linked to dysbiosis and poor hygiene
  • Eyelid and surface involvement in psoriasis, lichen planus, cicatricial dermatoses

7.3 Aesthetic Expressions with Functional Dimension

In modern clinical practice, many “aesthetic” conditions also have a functional dermophthalmologic basis:

  • Dark circles (periocular dark circles)

– often related to skin thinning, increased vascular transparency, microcirculatory congestion, chronic inflammation, and edema.

  • Swollen eyelids (edema)

– may result from inflammation, lymphatic stasis, allergy, chronic irritation, dysbiosis, and MGD.

  • “Droopy” lids / dermatochalasis

– caused by aging, connective tissue laxity, chronic inflammation, mechanical stress, with direct impact on visual field and the feeling of a “heavy” gaze.

Dermophthalmology does not claim to replace invasive or aesthetic therapies (e.g. blepharoplasty, fillers, lasers). It highlights that:

  • edema, dark circles, and drooping eyelids are often linked to chronic dysfunction of the Ophthalmoderma,
  • restoring hygiene, microcirculation, and lipid balance improves both comfort and the aesthetics of the gaze.

7.4 A Common Pathophysiological Denominator

Common pathophysiology = dysbiosis& lipid imbalance of the interface (microbial, cutaneous, lipid, immune, microcirculatory).

From this viewpoint:

  • “classic” and “aesthetic” conditions lie on the same continuum,
  • clinical management becomes more holistic,
  • communication with the patient becomes clearer.

CHAPTER 8 — PARALLEL WITH THE PERIODONTIUM

 

The evolution of Dermophthalmology strongly resembles the evolution of Periodontology.

 

8.1 Before the Concept of the Periodontium

Dentistry:

  • focused on the hard tissue (tooth),
  • saw gingivitis and bone loss as “local complications,”
  • had no clear concept of the system that supports the tooth.

8.2 The Birth of the Periodontium

With the introduction of the term Periodontium:

  • a new support system was defined: gums, alveolar bone, periodontal ligament, root cementum,
  • disease was reinterpreted as biofilm dysbiosis,
  • Periodontology emerged and the revolution of oral hygiene began.

8.3 Ophthalmoderma as the “Ocular Periodontium”

The parallel:

Periodontium

Ophthalmoderma

Tooth

Eye

Gums, bone, ligament

Eyelid, lashes, glands, ocular surface

Oral biofilm

Lid margin / ocular biofilm

Oral hygiene

Eye hygiene

In both cases:

  • inflammation starts at a dirty, neglected interface,
  • the solution is a combination of daily hygiene + professional treatment,
  • a new field is born (Periodontology then, Dermophthalmology now).

CHAPTER 9 — PREVENTIVE PHILOSOPHY: THE “EYE HYGIENE REVOLUTION”

 

9.1 From “Treat” to “Prevent”

Just as Dentistry:

  • evolved from extraction and treatment to daily oral hygiene,
Dermophthalmology proposes a new model:Daily care of eyelids and the interface, not just occasional treatment during flare-ups.

9.2 Pillars of Eye Hygiene

  • Daily cleansing of eyelids and eyelashes with specialized products (not just soap/water or harsh cosmetics).
  • Meibomian gland expression using thermal therapy / controlled-temperature heat masks& Meibomian Gland Evacuators (like Ophthalmogen).
  • Targeted anti-Demodex care where indicated.
  • Removal of make-up debris and residues.
  • Hydration of the tear–skin interface with suitable therapies.
  • Proper contact lens use and hygiene, both for the lenses and the eyelids.

9.3 No Threat to the Pharmaceutical Market

Crucially:

  • Eye hygiene does not replace pharmacological treatments,
  • does not reduce the need for drugs, artificial tears, anti-inflammatories, or innovative therapies,
  • instead, improves adherence,
  • makes treatments more effective,
  • and reduces relapses.

For the pharmaceutical and cosmeceutical industry, it:

  • opens new categories (eye hygiene, ophthalmo-cosmetics),
  • strengthens long-term therapeutic relationships,
  • promotes use of products with scientific backing.

9.4 Public Health & Health Policy

Ophthalmoderma disorders – blepharitis, MGD, dry eye, ocular rosacea – are not rare diagnoses but a daily burden on health systems, affecting productivity, quality of life, and resource use.

Dermophthalmology can support:

  • public health campaigns on proper Eye Hygiene, similar to oral hygiene campaigns,
  • guidelines for safe screen use, contact lenses, and cosmetics,
  • training programs for health professionals and the public, aiming at early recognition and prevention.

Integrating Eye Hygiene into public health protocols can reduce the long-term burden of ocular disease, with major benefits for patients and healthcare systems.

CHAPTER 10 — DERMOPHTHALMOLOGY & SYNERGIES

 

Dermophthalmology:

  • does not take space away from any specialty,
  • creates shared ground for collaboration.

10.1 For Ophthalmologists

  • improves understanding of MGD,
  • enhances treatment of dry eye, blepharitis, chalazion,
  • provides language to explain the role of daily care to patients,
  • leads to fewer relapses and more stable outcomes.

10.2 For Dermatologists

  • offers a framework for ocular manifestations of skin diseases,
  • facilitates collaboration with ophthalmologists,
  • helps in choosing therapies and cosmetics that respect the ocular surface.

10.3 For the Pharmaceutical & Cosmetic Industry

  • highlights the need for products that are both dermatologically and ophthalmologically safe,
  • establishes the category of Ophthalmo-Cosmetics (products for eyelids, eyelashes, periocular skin with clear ocular safety),
  • encourages research on combined protocols (therapeutic + hygiene).

10.4 For Patients

  • fewer chronic complaints,
  • clearer vision,
  • better contact lens tolerance,
  • less dependence on “just drops,”
  • active participation in the care of their own eyes.

10.5 Ophthalmo-Cosmetics & Periocular Aesthetics

Dermophthalmology is a natural bridge between clinical Ophthalmology, Dermatology, and the rapidly expanding field of periocular aesthetics.

The concept of OphthalmoCosmetics refers to products and care protocols for eyelids, eyelashes, and periocular skin that:

  • have a documented ocular safety profile,
  • respect the microbiome and lipid balance of the Ophthalmoderma,
  • incorporate principles of Eye Hygiene (cleansing, thermal regulation, massaging, biofilm management),
  • and at the same time enhance the aesthetic quality of the gaze (reduced edema, improved texture, brightness).

Thus, Dermophthalmology:

  • provides a scientific framework to a market that has so far mostly operated in cosmetic terms,
  • protects patients from practices that may harm the ocular surface,
  • and promotes development of products that do not force a trade-off between beauty and health.

CHAPTER 11 — THE SIGNIFICANCE & IMPACT OF THIS POSITION PAPER

 

This Position Paper is not merely a theoretical proposal. It is a foundational document that:

  • defines a new field,
  • bridges two major specialties,
  • provides scientific language where “grey zones” existed for decades,
  • and creates a coherent framework that explains thousands of clinical cases previously handled in a fragmented way.

Dermophthalmology did not “wait to be invented” by someone; it was inevitable, due to:

  • the explosion of dry eye/ blepharitis,
  • the rising burden of skin diseases with ocular involvement,
  • daily exposure to screens, pollutants, cosmetics, and contact lenses,
  • and the need of patients for an explanation that unites skin and eye.

This Position Paper provides that explanation.

 

11.1 Significance for the Medical Community

The document:

✓Establishes, for the first time, a clear, internationally applicable definition of Dermophthalmology,and delineates a new interdisciplinary field that does not cancel any specialty; on the contrary, it strengthens both Ophthalmology and Dermatology.

✓ Introduces Ophthalmoderma as a new target organ,a unified system that brings together:

  • eyelid skin,
  • eyelashes,
  • follicles,
  • Meibomian glands,
  • microbiome,
  • ocular surface.

This concept resolves long-standing diagnostic contradictions, such as:“How can a skin problem cause blurred vision?”

✓Provides a shared language for collaboration between specialties, enabling ophthalmologists and dermatologists to speak in common terms:

  • Meibomian–Follicle Axis
  • Tear–Skin Axis
  • interface microbiome
  • ophthalmo-cosmetics
  • eye hygiene protocols

✓Serves as a basis for future guidelines,similar in structure and influence to TFOS DEWS, ESCRS guidelines, AAO clinical frameworks.

✓ Opens pathways for educational programs(fellowships, workshops, certification courses in Dermophthalmology).

 

11.1.1 Theoretical & Conceptual Significance – A Position Paper One Generation Ahead of Current Medicine

Modern medicine is undergoing a profound paradigm shift: from organs to interfaces, from pathology to ecology, from tissue damage to microbiome-based homeostasis, from symptomatic to preventive dynamic regulation.

This Position Paper does not merely follow this globalscientific transition. It introduces it to Ophthalmology for the first time.By establishing Ophthalmoderma as the first true interface organ of the ocular system – and by defining MFA, TSA and ODI axes – the paper:

  • reframes the eyelid-lash-gland-tear unit as a single physiological ecosystem,
  • connects ocular surface medicine with thermodynamics, aerodynamics, microbiome science and interface body,
provides a unifying explanation for countless clinical presentations that were previously understood in isolation

11.2 Significance for Patients

This Position Paper:

✓Finally explains why so many patients present with mixed skin and ocular complaints,giving a name to their problem – not just a symptomatic description.

✓Provides a clear conceptual map:skin → eyelid → lash → glands → tear film → surface.

✓Highlights the absolute need for daily eyelid hygiene,not as a cosmetic habit but as a medical act of prevention — comparable to tooth-brushing.

✓ Reduces anxiety and uncertainty,by offering understanding, structure, and practical guidance.

✓ Improves the effectiveness of medications (without threatening the pharmaceutical market),because a clean, stable Ophthalmoderma responds better to any therapy.

 

11.3 Significance for the Pharmaceutical Industry, Ophthalmo-Cosmetics & Innovation

This Position Paper:

✓Threatens no pharmaceutical market,and does not imply reduced use of medicinal products;instead, it increases the need for:

  • specialized formulations,
  • new eye hygiene categories,
  • targeted products for blepharitis, MGD, demodex,
  • safe cosmetics for the periocular area.

✓ Creates a new market:Ophthalmo-Cosmetics —products that are both dermatologically and ophthalmologically safe.

✓ Predicts increased research activityin companies focusing on:

  • dry eye,
  • ocular surface disease,
  • glandular secretions,
  • the microbiome.

11.4 Significance for Research & Education

The document:

✓Provides a theoretical basis for new research protocols on:

  • the dermo-ocular microbiome,
  • lid physiology,
  • the lipid layer of the tear film.

✓Serves as a starting point for future publications, such as:

  • MFA Consensus Document,
  • TSA Clinical Applications,
  • Ophthalmo–Dermal Interface Atlas,
  • Eye Hygiene Guidelines.

✓Lays the foundation for international conferences, workshops, and training modules within the framework of the WOD – World Organization of Dermophthalmology (www.WOD.global).

11.5 Significance for Greece & International Visibility

Without any personal exaggeration, this Position Paper:

✓ Places Greece as the country of origin of a new medical concept,with historical roots in the Hippocratic philosophy of interfaces and holistic health.

✓ Links the present to the ancient Greek medical tradition,giving Greece the role of “birthplace” of a new scientific field.

✓Strengthens the international status of WOD – World Organization of Dermophthalmologyas an organization that promotes research, education, and clinical progress.

 11.6 Significance for Global Medical Progress

This Position Paper:

✓Opens the way to a medicine that studies interfaces, not only organs,representing the next era of medical science.

✓Responds to the needs of modern societies,where screens, pollution, cosmetics, contact lenses, and lifestyle have radically changed eyelid biology.

✓Proposes a preventive model that can influence hundreds of millions of people,in a simple, practical, and economically accessible way.

FINAL IMPACT SUMMARY

This Position Paper:        

  • establishes the new field,
  • offers a unified theoretical model,
  • creates an international reference point,
  • competes with no one,
  • unites disciplines,
  • explains patients’ real-world experience,
  • opens new therapeutic pathways,
  • and prepares the ground for the global adoption of Dermophthalmology.

It is a calm, scientific, collaborative document,yet it brings a cosmogonic shift in how we see the eye — and the skin that surrounds it.

CHAPTER 12 — THE VISION OF WOD (World Organization of Dermophthalmology)

 

WOD aims to:

  • Institutionalize Dermophthalmology as a recognized field of collaboration.
  • Create an international curriculum for ophthalmologists and dermatologists.
  • Develop clinical guidelines for blepharitis, MGD, ocular rosacea, etc., based on the Ophthalmoderma model.
  • Publish a series of Position Papers (Meibomian–Follicle Axis, Tear–Skin Axis, Ophthalmo–Dermal Interface, etc.).
  • Organize international conferences with major organizations (AAO, ESCRS, EADV, etc.), where Dermophthalmology will be discussed as a bridge between Ophthalmology and Dermatology.
  • Foster collaborations with research centers and industry for innovative products and protocols in Eye Hygiene and OphthalmoCosmetics.

CHAPTER 13 — CONCLUSION

 

Dermophthalmology:

  • is not a trend,
  • is not merely a new marketing term,
  • but the natural, scientifically mature evolution of Ophthalmology in the era of the microbiome, interfaces, and holistic understanding of the body.

Ophthalmoderma:

  • is recognized as a new target organ,
  • unites skin, eyelids, eyelashes, glands, microbiome, and ocular surface into a single system,
  • transforms eye health from a “narrow corneal perspective” to harmony of interfaces.

This Position Paper:

  • lays the foundation of the field,
  • honors the legacy of Hippocrates and Galen,
  • and invites the global medical community to a new dialogue:

How can we better care for the eyes, starting from the skin that surrounds them?

Authorship

Prepared by the Scientific Committee of the WOD – World Organization of Dermophthalmology (www.WOD.global)

Editor-in-Chief & Lead Concept Author:

John Tsakalos – Founder of the Dermophthalmology concept

With conceptual and scientific reference to the work of international ophthalmologists and researchers, including (indicatively, in alphabetical order):

  • Christophe Baudouin
  • George Cotsarelis
  • Marguerite McDonald
  • Stephen C. Pflugfelder
  • AníbalPeral
  • Kazuo Tsubota
  • Dmitry Niyazov
  • Michael Zegans

Russell Van Gelder

Acknowledgements

WOD expresses its deep gratitude:

  • to the international ophthalmology and dermatology communities,
  • to all researchers whose data and publications formed the basis upon which this framework was built,
  • to the Greek ophthalmologic and dermatologic societies and clinicians, whose work and observations highlighted in practice the importance of eyelid and ocular surface hygiene.

Without their contributions, Dermophthalmology could not have emerged as a coherent new field.

(For educational and scientific purposes – Athens, 2025)

Indicative Reference List (Short Reference List for the Position Paper)

  • Baudouin C. et al. (2016). A new approach for better comprehension of ocular surface diseases. Progress in Retinal and Eye Research.
  • McDonald M. et al. (2014–2016). Meibomian Gland Dysfunction and Dry Eye Disease. Eye & Contact Lens.
  • TFOS DEWS II (2017). Definition, Classification and Diagnosis of Dry Eye Disease. Ocul Surf.
  • Hu D., Mitchell G. (2015). Eyelashes divert airflow to protect the eye. Journal of The Royal Society Interface.
  • Zegans M., Van Gelder R. (2020). The ocular surface microbiome: moving from commensalism to pathogenesis. Curr Opin Microbiol.
  • Peral A. et al. (2023). The ocular–skin microbiome continuum. Ocular Surface Journal.
  • Niyazov D. et al. (2018). Ectodermal origin of ocular adnexa and ocular surface. Developmental Biology.
  • Cotsarelis G. (2006). Epithelial stem cells: a folliculocentric view. J Invest Dermatol.
  • Glickman I. (1960–1980). Clinical Periodontology.
  • Ιπποκράτης, Περὶ Ὄψιος (αρχαία ελληνικά κείμενα).
  • Γαληνός, De Usu Partium.

And the official reference to the foundational Dermophthalmology technical paper:

  • WOD – World Organization of Dermophthalmology (2025). Ophthalmoderma: The New Target Organ in Dermophthalmology. WOD Position Paper, Athens.

Historical Reference – The First Public Presentation (April 1, 2025)

The term Dermophthalmologywas first presented to the public on April 1, 2025, through an article published on www.Ophthalmogen.com entitled: “Dermophthalmology – The Field that Unites Ophthalmology and Dermatology” – https://ophthalmogen.com/2025/04/01/dermophthalmology/\

This publication defined for the first time the concept and its scope, establishing Greece as the birthplace of this new medical science. This text officially establishes the concept, marking its recognition as an autonomous interdisciplinary field.